Cargando…
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Drug resistance is a major obstacle to successful chemotherapy of primary liver cancer, which is associated with high expression of the multidrug resistance (MDR) gene product P-glycoprotein (Pgp), a multidrug efflux transporter. The most effective single agents in treatment of primary liver carcino...
Autores principales: | Lehne, G., De Angelis, P., Clausen, O. P., Rugstad, H. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077210/ https://www.ncbi.nlm.nih.gov/pubmed/8956784 |
Ejemplares similares
-
Doxorubicin and Aclarubicin: Shuffling Anthracycline
Glycans for Improved Anticancer Agents
por: Wander, Dennis P. A., et al.
Publicado: (2020) -
The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancer
por: Brouwer, Thomas P., et al.
Publicado: (2022) -
Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
por: Lehne, G., et al.
Publicado: (1998) -
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
por: De Angelis, P., et al.
Publicado: (1995) -
METABOLISM OF BILIRUBIN BY A CLONAL STRAIN OF RAT HEPATOMA CELLS
por: Rugstad, Hans E., et al.
Publicado: (1970)